Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-25-004223
Filing Date
2025-02-18
Accepted
2025-02-18 16:31:48
Documents
2
Period of Report
2025-02-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1410
2 executedpoadfaller.htm EX-24 11109
  Complete submission text file 0001437749-25-004223.txt   14258
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Issuer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O IMUNON, INC. 997 LENOX DRIVE, SUITE 100 LAWRENCEVILLE NJ 08648
Business Address
Faller Douglas Vincent (Reporting) CIK: 0002056033 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-15911 | Film No.: 25635520